Abstract Gut dysbiosis causes damage to the intestinal barrier and is associated with type 2 diabetes mellitus (T2DM). We tested the potential protective effects of probiotic BL21 and LRa05 on gut microbiota in type 2 diabetes mellitus mice and determined whether these effects were related to the modulation of gut microbiota. Thirty specific pathogen-free C57BL/6J mice...

Abstract This study explores the potential of Lacticaseibacillus rhamnosus LRa05 as a novel probiotic treatment for Candidal vaginitis. Isolated from fecal samples, LRa05 demonstrates superior antagonistic activity against Candida albicans, surpassing commercially available strains LGG, RC-14, and GR-1. Through in vitro and in vivo experiments, LRa05 significantly reduces...

  In an era where immune health is more critical than ever, the global rise in immune-related challenges has sparked widespread concern. According to the World Health Organization, the prevalence of chronic diseases linked to weakened immunity is increasing, particularly among aging populations. Social factors like stress, poor diet, and sedentary lifestyles further exacerbate these...